Attention New York Employers: Certain Employers Must Stock Opioid Antagonists by December 13 – Is Your Workplace Covered?

Effective December 13, 2026, S5922A amends the New York Labor Law to add a new section requiring all employers that are “federally mandated” to have first aid supplies readily available to treat injured employees to include an “opioid antagonist” in their supplies. 

While the law is short, there is a lot to unpack. This article dives deeper into employer coverage, requirements, and key compliance obligations under the New York State Department of Labor’s (NYDOL) proposed rules to implement the law.

On the Surface: General Requirements

Wading into the general requirements, let’s look at which employers are covered and what they need to stock.

Covered employers:  The law applies to private employers required by federal Occupational Health and Safety Administration (OSHA) standards to have first aid supplies readily available to treat injured employees. 

  • OSHA standards: The standard applies to employers without “an infirmary, clinic, or hospital in near proximity to the workplace[.]”

Opioid Antagonist: The law incorporates the New York Public Health Law § 3309 definition of “opioid antagonist,” which means a drug:

  • Approved by the Food and Drug Administration that “negates or neutralizes” the effects of opioids in the body; and
  • Limited to naloxone—commonly known as Narcan—and other drugs approved by the New York State Department of Health (NYDOH) for such purpose.

Deep Dive: Interpreting the Requirements

Diving deeper into coverage, let’s look at what it means to be in “near proximity” to emergency medical services. 

“Near Proximity”: While OSHA has never defined “near proximity,” prior guidance indicates that OSHA interprets the term to mean that—in the absence of an employee onsite who is trained to render first aid—emergency medical services must be available within:

  • 3 to 4 minutes for workplaces where serious accidents are possible; and
  • 15 minutes for workplaces where the possibility of serious work-related injuries is more remote, such as offices.

Employers in high-traffic areas may have additional considerations.  In a letter addressing the 3 to 4 minute timeframe, OSHA explains that:

  • An employer cannot rely on emergency services that are an averageof four minutes away because there is a possibilitythat such services could be more than four minutes away;
  • The purpose of the timeframes is to ensure that emergency medical services are available within the “critical minutes” following an injury; and
  • Any employers intending to rely on outside emergency medical responders must take “appropriate steps prior to any accident[,]” such as making arrangements with the service provider, to ensure that assistance will be available within the applicable timeframe.

On the Horizon: NYDOL’s Proposed Regulations

Coming up for air, let’s look what’s on the horizon for employers. On September 23, 2026, the NYDOL issued proposed rules that would require employers to:

  • Make a sufficient number of opioid antagonists available in the workplace, based on factors including workplace size and layout, staffing numbers, presence of high-risk individuals, nature of work, and prior workplace history of overdoses. 
  • Place opioid antagonists in areas easily accessible to administrators, based on factors including  workplace size and layout, or building security features that may hinder response time. 
  • Effectively communicate the location of opioid antagonists to employees and administrators.
  • Regularly inspect the opioid antagonist supply to ensure they are not tampered with, expired, missing, or moved from their locations; and properly dispose of and replace opioid antagonists, as appropriate.
  • Ensure there is at least one employee trained to administer opioid antagonists in the workplace during business hours. Training must be consistent with NYDOH materials and include, at a minimum, recognizing overdose symptoms, administering the opioid antagonist, and steps to take before and after administering the opioid antagonist.

Employers sharing a worksite may fulfill these requirements through a written joint compliance agreement, which must be provided to the NYDOL commissioner upon request.

Employer Takeaways

The comment period for the proposed rules ends on November 22, 2026 with the final rules expected in December. Employers can prepare for compliance with the following steps: 

  • Assess whether worksites are in “near proximity” to emergency medical services. 
  • Evaluate workplace-specific factors to determine the amount of opioid antagonists required and where they should be located. Opioid antagonists are available over-the-counter at participating pharmacies, and through NYC and New York State resources.
  • Train at least one employee on opioid antagonist administration to ensure coverage during business hours.
  • Establish procedures for regular inspections, replacement, and disposal of opioid antagonists.
  • Communicate the location of opioid antagonists to employees and administrators.
  • Consider a joint compliance agreement for shared worksites to fulfill compliance requirements.

SIGN UP

SIGN UP NOW to receive time sensitive employment law alerts and invitations to complimentary informational webinars and seminars.

"*" indicates required fields

By clicking this button and submitting information to us, you will be submitting certain personally identifiable information, or information which used together with other information, can be used to identify you and/or identify information about you, to Nukk-Freeman & Cerra, PC (“NFC”). Such information may be used by NFC to contact or identify you. Personally identifiable information may include, but is not limited to, your [name, phone number, address and/or] email address. We collect this information for the purpose of providing services, identifying and communicating with you, responding to your requests/inquiries, and improving our services. We may use your personally identifiable Information to contact you with time sensitive employment law e-alerts, marketing or promotional offers, invitations to complimentary and informational webinars and seminars, and other information that may be of interest to you. However, by providing any of the foregoing information to you, we are not creating an attorney-client relationship between you and NFC: nor are we providing legal advice to you. You may opt out of receiving any, or all, of these communications from us by following the unsubscribe link in any email we send. However, this will not unsubscribe you from receiving future communications from us which are based upon an independent request, relationship or act by you.